[Class : 5] Pharmaceutical Preparations Having Enhanced Drug Performance And/Or Drug Delivery Performance For The Treatment And/Or Prophylaxis Of Diseases Or Medical Conditions Such As Diabetes, Infections, Cancers And Inflammations, Or Of Diseases Or Medical Conditions That Affect The Peripheral Nerves, The Adrenergic And/Or Cholinergic Receptors, The Histamine Receptors, T...
[Class : 1] Chemicals Relating To Drug Performance And Or Drug Delivery Performance For Research Use And Manufacturing In The Biotechnical, Biomedical And Pharmaceutical Industries.
Documents
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-31122020
Form AOC-4(XBRL)-31122020
Form MGT-6-20032020_signed
-20032020
Form MGT-7-02012020_signed
List of share holders, debenture holders;-31122019
Copy of MGT-8-31122019
Form DIR-12-17112019_signed
Form AOC-4(XBRL)-17112019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-23102019
Optional Attachment-(2)-24072019
Notice of resignation;-24072019
Form DIR-12-24072019_signed
Evidence of cessation;-24072019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-24072019
Optional Attachment-(1)-24072019
Form ADT-1-19042019_signed
Copy of the intimation sent by company-19042019
Optional Attachment-(1)-19042019
Copy of resolution passed by the company-19042019
Copy of written consent given by auditor-19042019
Form DIR-11-19042019_signed
Form DIR-12-19042019_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-18042019
Evidence of cessation;-18042019
Acknowledgement received from company-18042019
Proof of dispatch-18042019
Notice of resignation filed with the company-18042019